A Randomized, Double-blinded Trial of a "rule of Threes" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery

Anesthesiology

Volumn 123, Issue 1, 2015, Pages 92-100

  Kovacheva, Vesela P ^a   Soens, Mieke A ^a   Tsen, Lawrence C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOPROST TROMETAMOL; EPHEDRINE; METHYLERGOMETRINE MALEATE; MISOPROSTOL; ONDANSETRON; OXYTOCIN; PHENYLEPHRINE; SODIUM CHLORIDE;

ADULT; ALGORITHM; ARTICLE; BLEEDING; BRADYCARDIA; CESAREAN SECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG INDUCED HEADACHE; ELECTIVE SURGERY; ELECTROCARDIOGRAPHY; FEMALE; FLUSHING; HUMAN; HYPOTENSION; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MUSCLE TONE; NAUSEA; NEW-ONSET ATRIAL FIBRILLATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RULE OF THREES ALGORITHM; SPINAL ANESTHESIA; THORAX PAIN; UTERINE ATONY; UTERINE TONE; UTERUS; COMPARATIVE STUDY; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; PHYSIOLOGY; PREGNANCY; PROCEDURES; UTERUS CONTRACTION;

ADULT; ALGORITHMS; CESAREAN SECTION; DOUBLE-BLIND METHOD; ELECTIVE SURGICAL PROCEDURES; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; OXYTOCIN; PREGNANCY; PROSPECTIVE STUDIES; UTERINE CONTRACTION;

EID: 84937429936     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000682     Document Type: Article

References (38)

1. Butwick AJ, Carvalho B, El-Sayed YY: Risk factors for obstetric morbidity in patients with uterine atony undergoing caesarean delivery. Br J Anaesth 2014; 113:661-8
2. Prendiville W, Elbourne D, Chalmers I: The effects of routine oxytocic administration in the management of the third stage of labour: An overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988; 95:3-16
3. Johnstone M: The cardiovascular effects of oxytocic drugs. Br J Anaesth 1972; 44:826-34
4. Thomas JS, Koh SH, Cooper GM: Haemodynamic effects of oxytocin given as i. v. bolus or infusion on women undergoing caesarean section. Br J Anaesth 2007; 98:116-9
5. Weis FR Jr, Markello R, Mo B, Bochiechio P: Cardiovascular effects of oxytocin. Obstet Gynecol 1975; 46:211-4
6. Pinder AJ, Dresner M, Calow C, Shorten GD, O'Riordan J, Johnson R: Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet Anesth 2002; 11:156-9
7. Thomas TA, Cooper GM: Maternal deaths from anaesthesia. An extract from Why mothers die 1997-1999, the Confidential Enquiries into Maternal Deaths in the United Kingdom. Br J Anaesth 2002; 89:499-508
8. Balki M, Cristian AL, Kingdom J, Carvalho JC: Oxytocin pretreatment of pregnant rat myometrium reduces the efficacy of oxytocin but not of ergonovine maleate or prostaglandin F 2. Reprod Sci 2010; 17:269-77
9. Magalhaes JK, Carvalho JC, Parkes RK, Kingdom J, Li Y, Balki M: Oxytocin pretreatment decreases oxytocin-induced myometrial contractions in pregnant rats in a concentration-dependent but not time-dependent manner. Reprod Sci 2009; 16:501-8
10. Carvalho JC, Balki M, Kingdom J, Windrim R: Oxytocin requirements at elective cesarean delivery: A dose-finding study. Obstet Gynecol 2004; 104(5 Pt 1):1005-10
11. Balki M, Ronayne M, Davies S, Fallah S, Kingdom J, Windrim R, Carvalho JC: Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol 2006; 107:45-50
12. Sheehan SR, Wedisinghe L, Macleod M, Murphy DJ: Implementation of guidelines on oxytocin use at caesarean section: A survey of practice in Great Britain and Ireland. Eur J Obstet Gynecol Reprod Biol 2010; 148:121-4
13. Mockler JC, Murphy DJ, Wallace EM: An Australian and New Zealand survey of practice of the use of oxytocin at elective caesarean section. Aust N Z J Obstet Gynaecol 2010; 50:30-5
14. Scott JR, Flint Porter T: Cesarean delivery, Danforth's Obstetrics and Gynecology, 10th edition. Edited by Gibbs RS, Karlan BY, Haney AF, Nygaard IE. Philadelphia, Lippincott, Williams & Wilkins, 2008, pp 491-503
15. Cunningham F, Leveno K, Bloom S, Spong C, Dashe J, Hoffman BL, Casey B, Sheffield J: William's Obstetrics, 24th edition. New York, McGraw Hill Medical, 2014, pp 595-6
16. Berghella V, Landon MB: Cesarean delivery, Obstetrics, 6th edition. Edited by Gabbe SG, Simpson JL, Niebyl JR. Philadelphia, Churchill Livingstone, 2012, pp 445-78
17. Balki M, Tsen L: Oxytocin protocols for cesarean delivery. Int Anesthesiol Clin 2014; 52:48-66
18. Butwick AJ, Coleman L, Cohen SE, Riley ET, Carvalho B: Minimum effective bolus dose of oxytocin during elective caesarean delivery. Br J Anaesth 2010; 104:338-43
19. Langesaeter E, Rosseland LA, Stubhaug A: Haemodynamic effects of repeated doses of oxytocin during caesarean delivery in healthy parturients. Br J Anaesth 2009; 103:260-2
20. Minehart RD, Pian-Smith MC, Walzer TB, Gardner R, Rudolph JW, Simon R, Raemer DB: Speaking across the drapes: Communication strategies of anesthesiologists and obstetricians during a simulated maternal crisis. Simul Healthc 2012; 7:166-70
21. McEvoy MD, Field LC, Moore HE, Smalley JC, Nietert PJ, Scarbrough SH: The effect of adherence to ACLS protocols on survival of event in the setting of in-hospital cardiac arrest. Resuscitation 2014; 85:82-7
22. Rudolph JW, Simon R, Rivard P, Dufresne RL, Raemer DB: Debriefing with good judgment: Combining rigorous feedback with genuine inquiry. Anesthesiol Clin 2007; 25:361-76
23. Tsen LC, Balki M: Oxytocin protocols during cesarean delivery: Time to acknowledge the risk/benefit ratio? Int J Obstet Anesth 2010; 19:243-5
24. Leake RD, Weitzman RE, Fisher DA: Pharmacokinetics of oxytocin in the human subject. Obstet Gynecol 1980; 56:701-4
25. Butwick AJ, Coleman L, Cohen SE, Riley ET, Carvalho B: Minimum effective bolus dose of oxytocin during elective caesarean delivery. Br J Anaesth 2010; 104:338-43
26. Why Mothers Die. The Confidential Enquiries into Maternal Deaths in the United Kingdom 1997-1999. London, Royal College of Obstetrics and Gynaecology Press, 2001
27. Thomas JS, Koh SH, Cooper GM: Haemodynamic effects of oxytocin given as i. v. bolus or infusion on women undergoing caesarean section. Br J Anaesth 2007; 98:116-9
28. Bhattacharya S, Ghosh S, Ray D, Mallik S, Laha A: Oxytocin administration during cesarean delivery: Randomized controlled trial to compare intravenous bolus with intravenous infusion regimen. J Anaesthesiol Clin Pharmacol 2013; 29:32-5
29. Davies JM, Posner KL, Lee LA, Cheney FW, Domino KB: Liability associated with obstetric anesthesia: A closed claims analysis. Anesthesiology 2009; 110:131-9
30. Yeung J, Perkins GD: Timing of drug administration during CPR and the role of simulation. Resuscitation 2010; 81:265-6
31. Rozich JD, Howard RJ, Justeson JM, Macken PD, Lindsay ME, Resar RK: Standardization as a mechanism to improve safety in health care. Jt Comm J Qual Saf 2004; 30:5-14
32. Toledo P, McCarthy RJ, Hewlett BJ, Fitzgerald PC, Wong CA: The accuracy of blood loss estimation after simulated vaginal delivery. Anesth Analg 2007; 105:1736-40
33. Sarna MC, Soni AK, Gomez M, Oriol NE: Intravenous oxytocin in patients undergoing elective cesarean section. Anesth Analg 1997; 84:753-6
34. Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC: Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: A randomized controlled trial. Obstet Gynecol 2001; 98:386-90
35. Sartain JB, Barry JJ, Howat PW, McCormack DI, Bryant M: Intravenous oxytocin bolus of 2 units is superior to 5 units during elective caesarean section. Br J Anaesth 2008; 101:822-6
36. Svanström MC, Biber B, Hanes M, Johansson G, Näslund U, Bålfors EM: Signs of myocardial ischaemia after injection of oxytocin: A randomized double-blind comparison of oxytocin and methylergometrine during caesarean section. Br J Anaesth 2008; 100:683-9
37. Fortner CL, Manley ES Jr, Woodbury RA: Effects of synthetic oxytocin with and without preservatives upon coronary blood flow in the dog. J Pharmacol Exp Ther 1969; 165:258-66
38. Jonsson M, Hanson U, Lidell C, Nordén-Lindeberg S: ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial. BJOG 2010; 117:76-83